Yi Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yi Tang has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Huan Xiao
Department of Ultrasound, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China
6 shared publicationsChunjiang Yang
Department of Ultrasound, Children’s Hospital of Chongqing Medical University, Chongqing, P.R. China
4 shared publicationsJingyu Chen
Department of Ultrasound, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Chongqing, China
4 shared publications- Jingyu Chen
Department of Ultrasound Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases Ministry of Education Key Laboratory of Child Development and Disorders Chongqing China
4 shared publications Yang Gao
Department of Ultrasound, Children’s Hospital of Chongqing Medical University, Chongqing, P.R. China
4 shared publications- Xiaojuan Ji
Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
3 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Clinical and ultrasound characteristics associated with pediatric osteomyelitis in comparison with soft tissue infection
- 17 August 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessClinical and ultrasound characteristics associated with pediatric osteomyelitis in comparison with soft tissue infection
- Open Access
- 26 March 2026
- Published by Wiley in Pediatric Discovery
- Vol. 4 (1) , e70038
Intracavernous and Intravenous Use of Contrast‐Enhanced Ultrasound in Children: A Report of Five Cases and Review of the Literature
- 26 March 2026
- Published by Wiley in Pediatric Discovery
- Vol. 4 (1) , e70038
Open AccessIntracavernous and Intravenous Use of Contrast‐Enhanced Ultrasound in Children: A Report of Five Cases and Review of the Literature
- Open Access
- 20 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (6) , 923
The Safety of Ultrasound Contrast Agents in Children
Background/Objectives: Retrospective analysis of the safety of contrast-enhanced ultrasound in children. Methods: A retrospective analysis was conducted on children who underwent contrast-enhanced ultrasound (CEUS) examinations at the Children’s Hospital of Chongqing Medical University from 2019 to 2025. Adverse reactions were classified into three grades (mild, moderate, and severe) based on severity. Following the pharmacological classification, the types of adverse reactions are divided into “Type A reactions” and “Type B reactions” and further classified into immediate and delayed reactions according to the timing of occurrence. Results: This study included 1604 pediatric patients who underwent a total of 1924 intravenous CEUS examinations. Seven patients experienced adverse reactions, yielding an overall adverse reaction incidence rate of 0.436% (95% Confidence Interval: 0.18–0.90%). Among these, six reactions were mild (6/7, 85.71%), and one was moderate (1/7, 14.29%). Among the seven patients, 16 clinical manifestations were recorded, comprising 12 type B reactions (12/16, 75%) and 4 type A reactions (4/16, 25%). Furthermore, all adverse reactions were classified as immediate onset. Conclusions: Under the conditions of this study, CEUS demonstrated good safety in the pediatric population, with no serious adverse events observed.
- 20 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (6) , 923
Open AccessThe Safety of Ultrasound Contrast Agents in Children
Background/Objectives: Retrospective analysis of the safety of contrast-enhanced ultrasound in children. Methods: A retrospective analysis was conducted on children who underwent contrast-enhanced ultrasound (CEUS) examinations at the Children’s Hospital of Chongqing Medical University from 2019 to 2025. Adverse reactions were classified into three grades (mild, moderate, and severe) based on severity. Following the pharmacological classification, the types of adverse reactions are divided into “Type A reactions” and “Type B reactions” and further classified into immediate and delayed reactions according to the timing of occurrence. Results: This study included 1604 pediatric patients who underwent a total of 1924 intravenous CEUS examinations. Seven patients experienced adverse reactions, yielding an overall adverse reaction incidence rate of 0.436% (95% Confidence Interval: 0.18–0.90%). Among these, six reactions were mild (6/7, 85.71%), and one was moderate (1/7, 14.29%). Among the seven patients, 16 clinical manifestations were recorded, comprising 12 type B reactions (12/16, 75%) and 4 type A reactions (4/16, 25%). Furthermore, all adverse reactions were classified as immediate onset. Conclusions: Under the conditions of this study, CEUS demonstrated good safety in the pediatric population, with no serious adverse events observed.
- 15 March 2026
- Vol. 28 (3) , 371-377
[Recent advances in predicting the surgical timing for neonatal necrotizing enterocolitis].
Neonatal necrotizing enterocolitis (NEC) is a life-threatening acute gastrointestinal disorder in preterm infants, characterized by high morbidity and mortality. Approximately 20%-60% of infants with NEC require emergency surgical intervention due to intestinal perforation or failure of medical management, and mortality risk increases markedly when surgery follows perforation. Traditional imaging and biomarkers have limited performance in predicting surgical timing. In recent years, multimodal imaging technologies, novel biomarkers, and machine learning algorithms have shown higher predictive value than conventional tests and clinical indicators for determining surgical timing in NEC. This review summarizes recent advances in predictive methodologies for surgical decision-making in NEC.
- 15 March 2026
- Vol. 28 (3) , 371-377
[Recent advances in predicting the surgical timing for neonatal necrotizing enterocolitis].
Neonatal necrotizing enterocolitis (NEC) is a life-threatening acute gastrointestinal disorder in preterm infants, characterized by high morbidity and mortality. Approximately 20%-60% of infants with NEC require emergency surgical intervention due to intestinal perforation or failure of medical management, and mortality risk increases markedly when surgery follows perforation. Traditional imaging and biomarkers have limited performance in predicting surgical timing. In recent years, multimodal imaging technologies, novel biomarkers, and machine learning algorithms have shown higher predictive value than conventional tests and clinical indicators for determining surgical timing in NEC. This review summarizes recent advances in predictive methodologies for surgical decision-making in NEC.
- Open Access
- 13 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 571
Early Prediction of Biliary Atresia Using Combi-Elastography in Infants ≤ 60 Days of Age
Background: To improve the early recognition of biliary atresia (BA) and timely treatment, this study developed a predictive model integrating combi-elastography, a novel form of elastography, to distinguish biliary atresia from other cholestatic liver diseases (non-BA) in infants. Method: A total of 69 children aged < 60 days with cholestatic hepatitis were retrospectively enrolled. All patients underwent conventional ultrasonography, combi-elastography, and laboratory testing. The variables were selected using logistic regression to construct a nomogram model, and the performance of the model was evaluated. Results: Multifactorial logistic regression analysis indicated that GGT (p = 0.015), the gallbladder morphology (p = 0.017), and the fibrosis index of the combi-elastography (p = 0.017) could be used as independent predictors to differentiate BA from other causes of cholestasis. A nomogram model constructed with these three indexes showed better performance, with an area under the operating characteristic curve (AUC) of 0.887 (0.823, 0.952) (p < 0.001), sensitivity of 86.4%, and specificity of 76.0%. Using 1000 Bootstrap resamples for internal validation of the model, the predictive effect of the nomogram model to identify biliary atresia from other cholestatic liver diseases was in good agreement with the actual situation. Decision-curve analysis showed that the use of the nomogram model to predict biliary atresia gained more clinical value at a risk threshold of 0.10–0.80. Conclusion: The nomogram constructed integrating combi-elastography and liver function indices shows promising value for predicting the risk for developing biliary atresia.
- 13 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 571
Open AccessEarly Prediction of Biliary Atresia Using Combi-Elastography in Infants ≤ 60 Days of Age
Background: To improve the early recognition of biliary atresia (BA) and timely treatment, this study developed a predictive model integrating combi-elastography, a novel form of elastography, to distinguish biliary atresia from other cholestatic liver diseases (non-BA) in infants. Method: A total of 69 children aged < 60 days with cholestatic hepatitis were retrospectively enrolled. All patients underwent conventional ultrasonography, combi-elastography, and laboratory testing. The variables were selected using logistic regression to construct a nomogram model, and the performance of the model was evaluated. Results: Multifactorial logistic regression analysis indicated that GGT (p = 0.015), the gallbladder morphology (p = 0.017), and the fibrosis index of the combi-elastography (p = 0.017) could be used as independent predictors to differentiate BA from other causes of cholestasis. A nomogram model constructed with these three indexes showed better performance, with an area under the operating characteristic curve (AUC) of 0.887 (0.823, 0.952) (p < 0.001), sensitivity of 86.4%, and specificity of 76.0%. Using 1000 Bootstrap resamples for internal validation of the model, the predictive effect of the nomogram model to identify biliary atresia from other cholestatic liver diseases was in good agreement with the actual situation. Decision-curve analysis showed that the use of the nomogram model to predict biliary atresia gained more clinical value at a risk threshold of 0.10–0.80. Conclusion: The nomogram constructed integrating combi-elastography and liver function indices shows promising value for predicting the risk for developing biliary atresia.
- Open Access
- 3 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 474
A Preliminary Study on Contrast Enhanced Ultrasound Characteristics of Solid Pseudopapillary Neoplasms and Pancreatoblastoma in Children
Objective: Solid pseudopapillary neoplasms (SPN) and pancreatoblastoma (PB) have a low overall incidence but represent the most common pancreatic tumors in childhood. Currently, there is a lack of systematic descriptions of contrast-enhanced ultrasound (CEUS) features for these two tumors in pediatric populations. This study aims to retrospectively analyze and compare the CEUS characteristics of SPN and PB to explore key imaging differentiation points. Methods: This retrospective study collected data on 22 patients with solid pseudopapillary neoplasms and pancreatic blastomas of the pancreas who were pathologically diagnosed at a children’s hospital between September 2019 and May 2025. The ultrasound contrast-enhanced imaging findings for both tumor types were summarized and analyzed. Two physicians with different levels of experience performed qualitative analysis of the contrast-enhanced images, while quantitative analysis was conducted using time–intensity curve (TIC) analysis software. Results: This study included a total of 22 pediatric patients (19 with SPN and 3 with PB). Significant differences existed between the two groups in age (13.51 years vs. 2.94 years) and Ki-67 index (5.00% vs. 30.00%). Qualitative analysis revealed high heterogeneity in SPN enhancement patterns, with capsular enhancement with cystic components being the most common (42.11%). All PBs (100%) consistently demonstrated the “disorganized nourishing vessels” sign. Quantitative analysis revealed that PBs exhibited numerically higher IMAX values (179.84% vs. 60.56%) and faster WoR trends (773.88 vs. 275.38). Inter-observer consistency analysis supported measurement reliability (key parameters ICC > 0.80). Conclusions: This preliminary study indicates differences in CEUS characteristics between pediatric SPN and PB; PB tends to exhibit rapid, high enhancement with chaotic feeding vessels and rapid washout, whereas SPN more commonly presents with moderate, slow enhancement patterns, often accompanied by features associated with cystic components. These findings provide new hemodynamic clues for their imaging differentiation. Given the extremely small sample size of PB cases, the above conclusions should be regarded as preliminary hypotheses awaiting validation in future large-scale studies.
- 3 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 474
Open AccessA Preliminary Study on Contrast Enhanced Ultrasound Characteristics of Solid Pseudopapillary Neoplasms and Pancreatoblastoma in Children
Objective: Solid pseudopapillary neoplasms (SPN) and pancreatoblastoma (PB) have a low overall incidence but represent the most common pancreatic tumors in childhood. Currently, there is a lack of systematic descriptions of contrast-enhanced ultrasound (CEUS) features for these two tumors in pediatric populations. This study aims to retrospectively analyze and compare the CEUS characteristics of SPN and PB to explore key imaging differentiation points. Methods: This retrospective study collected data on 22 patients with solid pseudopapillary neoplasms and pancreatic blastomas of the pancreas who were pathologically diagnosed at a children’s hospital between September 2019 and May 2025. The ultrasound contrast-enhanced imaging findings for both tumor types were summarized and analyzed. Two physicians with different levels of experience performed qualitative analysis of the contrast-enhanced images, while quantitative analysis was conducted using time–intensity curve (TIC) analysis software. Results: This study included a total of 22 pediatric patients (19 with SPN and 3 with PB). Significant differences existed between the two groups in age (13.51 years vs. 2.94 years) and Ki-67 index (5.00% vs. 30.00%). Qualitative analysis revealed high heterogeneity in SPN enhancement patterns, with capsular enhancement with cystic components being the most common (42.11%). All PBs (100%) consistently demonstrated the “disorganized nourishing vessels” sign. Quantitative analysis revealed that PBs exhibited numerically higher IMAX values (179.84% vs. 60.56%) and faster WoR trends (773.88 vs. 275.38). Inter-observer consistency analysis supported measurement reliability (key parameters ICC > 0.80). Conclusions: This preliminary study indicates differences in CEUS characteristics between pediatric SPN and PB; PB tends to exhibit rapid, high enhancement with chaotic feeding vessels and rapid washout, whereas SPN more commonly presents with moderate, slow enhancement patterns, often accompanied by features associated with cystic components. These findings provide new hemodynamic clues for their imaging differentiation. Given the extremely small sample size of PB cases, the above conclusions should be regarded as preliminary hypotheses awaiting validation in future large-scale studies.
- Open Access
- 4 June 2025
- Published by Springer Nature in Cancer Cell International
- Vol. 25 (1) , 1-12
Genetically engineered bacteria-based nanocomposite synergistic HIFU for tumor therapy by changing the acoustic environment of tumor tissues
High-intensity focused ultrasound (HIFU) is a novel non-invasive technique with tremendous potential applications. However, ensuring effectiveness and safety of HIFU therapy remains a substantial challenge. Changing the acoustic environment of tumor tissues is an emerging way to solve this problem. In this study, we successfully constructed a bacteria-based nanocomposite, consisting genetically engineered bacteria (GVs-E.coli) and perfluorohexane/poly(lactic-co-glycolic acid) (PFH/PLGA) nanoparticles, which is denoted as GVs-E@PP NPs. We demonstrated that GVs-E@PP NPs could selectively target and proliferate in the tumor sites, and enhance the efficacy of HIFU therapy by changing the acoustic environment of tumor tissues. Specifically, they induced an increase in collagen fibers, elastic modulus, sound velocity and sound attenuation within tumor tissues, while simultaneously reducing tumor angiogenesis. These comprehensive changes facilitated the therapeutic efficacy of HIFU treatment. In summary, this approach represents an innovative therapeutic strategy to enhance HIFU synergy in tumor treatment.
- 4 June 2025
- Published by Springer Nature in Cancer Cell International
- Vol. 25 (1) , 1-12
Open AccessGenetically engineered bacteria-based nanocomposite synergistic HIFU for tumor therapy by changing the acoustic environment of tumor tissues
High-intensity focused ultrasound (HIFU) is a novel non-invasive technique with tremendous potential applications. However, ensuring effectiveness and safety of HIFU therapy remains a substantial challenge. Changing the acoustic environment of tumor tissues is an emerging way to solve this problem. In this study, we successfully constructed a bacteria-based nanocomposite, consisting genetically engineered bacteria (GVs-E.coli) and perfluorohexane/poly(lactic-co-glycolic acid) (PFH/PLGA) nanoparticles, which is denoted as GVs-E@PP NPs. We demonstrated that GVs-E@PP NPs could selectively target and proliferate in the tumor sites, and enhance the efficacy of HIFU therapy by changing the acoustic environment of tumor tissues. Specifically, they induced an increase in collagen fibers, elastic modulus, sound velocity and sound attenuation within tumor tissues, while simultaneously reducing tumor angiogenesis. These comprehensive changes facilitated the therapeutic efficacy of HIFU treatment. In summary, this approach represents an innovative therapeutic strategy to enhance HIFU synergy in tumor treatment.
- Open Access
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0200
Breaking the Chains of Therapeutic Blockade: Pyroptosis-Induced Photothermal-Chemotherapy with Targeted Nanoprobes in Triple-Negative Breast Cancer
There is an important clinical need and social significance, especially for young patients, to explore a new breast-conserving strategy that is not dependent on biomarkers for anti-triple-negative breast cancer. Disulfiram, historically employed for the treatment of chronic alcoholism, has recently emerged as a promising antitumor agent in combination with Cu 2+ . However, reported disulfiram–Cu 2+ codelivery regimens often suffer from instability as well as inadequate drug metabolism, which is detrimental to the production and action of the antitumor active ingredient copper(II) bis(diethyldithiocarbamate). To address this obstacle, this study tested nanosystems ICG-CuET@PLGA-CS-HA (IC@PCH) nanoparticles (NPs) carrying the chemotherapeutic agent copper(II) bis(diethyldithiocarbamate) and photosensitizer indocyanine green for the efficient delivery of antitumor drugs. Benefiting from the involvement of hyaluronic acid, the prepared IC@PCH NPs not only targeted CD44 on the surface of tumor cells but also showed a longer in vivo circulation time. The in vitro and in vivo results demonstrated that IC@PCH NP-mediated photothermal-chemotherapy treatment led to pyroptosis via the NLRP3/caspase-1 classical pathway, which had a significant therapeutic effect on triple-negative breast cancer. In addition, targeting IC@PCH NPs allows photoacoustic–magnetic resonance–fluorescence trimodal imaging, which is capable of detecting more insidious cancer foci and opens up new avenues for precise cancer diagnosis and treatment.
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0200
Open AccessBreaking the Chains of Therapeutic Blockade: Pyroptosis-Induced Photothermal-Chemotherapy with Targeted Nanoprobes in Triple-Negative Breast Cancer
There is an important clinical need and social significance, especially for young patients, to explore a new breast-conserving strategy that is not dependent on biomarkers for anti-triple-negative breast cancer. Disulfiram, historically employed for the treatment of chronic alcoholism, has recently emerged as a promising antitumor agent in combination with Cu 2+ . However, reported disulfiram–Cu 2+ codelivery regimens often suffer from instability as well as inadequate drug metabolism, which is detrimental to the production and action of the antitumor active ingredient copper(II) bis(diethyldithiocarbamate). To address this obstacle, this study tested nanosystems ICG-CuET@PLGA-CS-HA (IC@PCH) nanoparticles (NPs) carrying the chemotherapeutic agent copper(II) bis(diethyldithiocarbamate) and photosensitizer indocyanine green for the efficient delivery of antitumor drugs. Benefiting from the involvement of hyaluronic acid, the prepared IC@PCH NPs not only targeted CD44 on the surface of tumor cells but also showed a longer in vivo circulation time. The in vitro and in vivo results demonstrated that IC@PCH NP-mediated photothermal-chemotherapy treatment led to pyroptosis via the NLRP3/caspase-1 classical pathway, which had a significant therapeutic effect on triple-negative breast cancer. In addition, targeting IC@PCH NPs allows photoacoustic–magnetic resonance–fluorescence trimodal imaging, which is capable of detecting more insidious cancer foci and opens up new avenues for precise cancer diagnosis and treatment.
- Open Access
- 16 November 2024
- Published by Springer Nature in Journal of Big Data
- Vol. 11 (1) , 1-13
Automatic identification and classification of pediatric glomerulonephritis on ultrasound images based on deep learning and radiomics
- 16 November 2024
- Published by Springer Nature in Journal of Big Data
- Vol. 11 (1) , 1-13
Open AccessAutomatic identification and classification of pediatric glomerulonephritis on ultrasound images based on deep learning and radiomics
- 4 April 2024
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 50 (6) , 954-960
A Preliminary Study on the Application of Contrast-Enhanced Ultrasonography in Children With Peripheral Neuroblastic Tumors
- 4 April 2024
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 50 (6) , 954-960
A Preliminary Study on the Application of Contrast-Enhanced Ultrasonography in Children With Peripheral Neuroblastic Tumors